Evaluation of Regulation Focused Psychotherapy for Children (RFP-C)
Oppositional Defiant Disorder, Oppositional Defiant Disorder in Children
About this trial
This is an interventional treatment trial for Oppositional Defiant Disorder focused on measuring oppositional defiant disorder, regulation focused psychotherapy for children, emotion regulation, psychodynamic psychotherapy
Eligibility Criteria
Inclusion Criteria:
- Experiencing symptoms of ODD
- Fluent in English
- Not diagnosed with severe autism spectrum disorder
- Able to attend therapy twice a week for 10 weeks in the Bronx
- No concurrent therapy services (psychosocial groups and Individualized Education Plan supports are acceptable)
Exclusion Criteria:
- Active Administration for Children's Services (ACS)/Child Protective Services (CPS) involvement
- Severe autism spectrum disorder
Sites / Locations
- Ferkauf Graduate School of Psychology - Yeshiva University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
RFP-C
Wait List control
Regulation Focused Psychotherapy for Children (RFP-C; Hoffman & Rice with Prout, 2015) is a novel, manualized, time-limited psychodynamic treatment approach for children who manifest disruptive behaviors and emotional dysregulation. Throughout the 16 sessions of play therapy and four parent meetings, the clinician works with the parents and the child to increase understanding that all behavior, even disruptive behavior, has meaning in the service of emotional and behavioral regulation. This insight leads to a decreased need and reliance to act on the distressing emotions (e.g. less need for disruptive behaviors) and an increased ability to tolerate, work through, and talk about the feelings that previously needed to be warded off.
Participants assigned to this condition will receive no intervention. They may continue on current medication regimens (no major changes) but may not be enrolled in psychological treatments. They will be evaluated weekly via phone call with primary caregiver. At the conclusion of this 10-week wait list period all participants assigned to this condition will receive RFP-C treatment.